Why Do So Many Animal Health Products Fail to Deliver ROI?

You can have a groundbreaking scientific discovery, secure regulatory approval, and still fail in the market. It's a tough reality, but industry data suggests that a significant percentage of animal health products never deliver a return on investment (ROI) post-launch.

Let's break down why this happens.

Many innovators assume that if they build a better mousetrap, the world will beat a path to their door. In animal health, that's rarely true. The path from a successful clinical trial to a profitable product is littered with pitfalls.

Clinical adoption barriers are a huge one. Veterinarians and producers are practical. If your product disrupts established workflows, adds unnecessary steps, or doesn't clearly solve a pressing problem, they won't use it. It doesn't matter how brilliant the technology is if it doesn't fit into their daily reality.

Then there's the issue of value-based pricing. If you price your product above its perceived value, it will struggle to gain traction. If you price it too low, it might signal poor quality. Understanding what the market will bear is a delicate science.

And of course, there's the challenge of distribution. Even the best product won't succeed if it's not in the right channels or if you have weak partnerships with distributors. You can't build a commercial success on a product that veterinarians can't easily get their hands on.